VeriMom¿Es magnolia kobus bark extract seguro durante el embarazo?
No EU ban/restriction or harmonised CMR classification found for Magnolia kobus bark extract/CAS 223749-80-2 (CosIng entry exists), but animal studies on major Magnolia bark constituents (honokiol, magnolol) report embryo–fetal effects or placental/uterine effects in rodents, so reproductive hazard is suspected. Example studies: an embryo–fetal toxicity study of honokiol in pregnant rats and animal data showing magnolol alters placental morphology and can inhibit uterine contraction. CosIng/industry listings and EWG do not override these animal findings. Sources: PubMed studies and WHO monograph noted below.
Alternativas seguras a magnolia kobus bark extract en el embarazo | VeriMom
Related ingredients
Frequently asked questions
- ¿Es magnolia kobus bark extract seguro durante el embarazo?
- No EU ban/restriction or harmonised CMR classification found for Magnolia kobus bark extract/CAS 223749-80-2 (CosIng entry exists), but animal studies on major Magnolia bark constituents (honokiol, magnolol) report embryo–fetal effects or placental/uterine effects in rodents, so reproductive hazard is suspected. Example studies: an embryo–fetal toxicity study of honokiol in pregnant rats and animal data showing magnolol alters placental morphology and can inhibit uterine contraction. CosIng/industry listings and EWG do not override these animal findings. Sources: PubMed studies and WHO monograph noted below.
- ¿Es magnolia kobus bark extract seguro durante la lactancia?
- No harmonised classification or EU Annex II/III listing found; however the same animal data and mechanistic evidence (placental/uterine activity and systemic activity of isolated constituents) justify a suspected hazard and demonstrated mechanism. Transfer into breastmilk is not directly studied for the extract, but systemic bioactivity of honokiol/magnolol supports cautious classification as suspected (h=2). Exposure from topical cosmetic use is likely low but measurable.
- ¿Es magnolia kobus bark extract seguro para la piel del bebé?
- Baby skin exposure: do not increase h or m without infant-specific evidence, but exposure score is increased because infant skin has higher absorption. The ingredient contains small lipophilic active constituents (honokiol/magnolol) with demonstrated systemic activity in animals; therefore exposure for 0–3 yr olds is scored higher (adult e=1 → baby e=2). No infant-specific safety studies located.
- ¿Cómo puntúa VeriMom a magnolia kobus bark extract?
- VeriMom puntúa magnolia kobus bark extract en 40/100 (riesgo medio) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
- ¿Cuáles son las alternativas seguras a magnolia kobus bark extract en el embarazo?
- Consulta nuestra lista de alternativas seguras a magnolia kobus bark extract según función similar y clasificación sin riesgos conocidos.
Comprueba cualquier etiqueta en 2 segundos
Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.
Aviso Médico
Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.